Literature DB >> 2276312

Macular oscillatory potentials in humans. Macular OPs.

Y Miyake1.   

Abstract

Studies of the focal macular electroretinogram (ERG) have been made with special reference to oscillatory potentials (OPs) by using a fundus monitoring system in humans. Human macular OPs consist of 3 to 4 wavelets (mean peak interval, approximately 6.5 msec). The distribution of OPs in relation to those in a- and b-waves was studied. The amplitudes of a-waves, b-waves, and OPs of the upper macula were significantly larger than those of the lower macula. The distribution of OPs is relatively sparse in the fovea, becoming more dense than the a- and b-waves from the fovea toward the parafovea, and differing even more toward the perifovea. There was no statistical difference of amplitude in a- and b-waves between nasal and temporal macula. The amplitude of OPs in the temporal macula, however, was significantly larger than in the nasal macula. In some macular diseases, such as diabetic maculopathy, cystoid macular edema, or the convalescent stage of central serous chorioretinopathy, macular OPs were selectively reduced, leaving the a- and b-waves intact. Macular OPs can provide a new aspect of macular function and can be a sensitive indicator to assess that function in macular diseases.

Entities:  

Mesh:

Year:  1990        PMID: 2276312     DOI: 10.1007/bf00146547

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  26 in total

Review 1.  [Studies of local macular ERG].

Authors:  Y Miyake
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1988-09

2.  Electrophysiological assessment of aphakic cystoid macular oedema.

Authors:  J Salzman; W Seiple; R Carr; L Yannuzzi
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

Review 3.  The eclectroretinogram: its components and their origins.

Authors:  K T Brown
Journal:  Vision Res       Date:  1968-06       Impact factor: 1.886

4.  The human electroretinogram and occipital potential in response to focal illumination of the retina.

Authors:  J H Jacobson; K Kawasaki; T Hirose
Journal:  Invest Ophthalmol       Date:  1969-10

5.  [Studies on the local electric response of the human retina. I. An instrument for stimulating local retinal areas in various photic conditions].

Authors:  M Nagata; Y Honda
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1970-04

6.  The ganglion cell and cone distributions in the monkey's retina: implications for central magnification factors.

Authors:  V H Perry; A Cowey
Journal:  Vision Res       Date:  1985       Impact factor: 1.886

7.  Origin of the oscillatory potentials in the primate retina.

Authors:  H Heynen; L Wachtmeister; D van Norren
Journal:  Vision Res       Date:  1985       Impact factor: 1.886

8.  Checkerboard-evoked potentials: topography and latency for onset, offset, and reversal.

Authors:  W Skrandies; M Richter; D Lehmann
Journal:  Prog Brain Res       Date:  1980       Impact factor: 2.453

9.  The standing potential of the human eye reflects differences between upper and lower retinal areas.

Authors:  W Skrandies; M Baier
Journal:  Vision Res       Date:  1986       Impact factor: 1.886

10.  Stimulus deprivation amblyopia. Simultaneous recording of local macular electroretinogram and visual evoked response.

Authors:  Y Miyake; S Awaya
Journal:  Arch Ophthalmol       Date:  1984-07
View more
  12 in total

1.  Distribution of oscillatory components in the central retina.

Authors:  M A Bearse; Y Shimada; E E Sutter
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

2.  Effect of experimental glaucoma in primates on oscillatory potentials of the slow-sequence mfERG.

Authors:  Nalini V Rangaswamy; Wei Zhou; Ronald S Harwerth; Laura J Frishman
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-02       Impact factor: 4.799

3.  Oscillatory potentials of the slow-sequence multifocal ERG in primates extracted using the Matching Pursuit method.

Authors:  Wei Zhou; Nalini Rangaswamy; Periklis Ktonas; Laura J Frishman
Journal:  Vision Res       Date:  2007-05-23       Impact factor: 1.886

4.  Analysis of multifocal electroretinograms from a population with type 1 diabetes using partial least squares reveals spatial and temporal distribution of changes to retinal function.

Authors:  Tom Wright; Filomeno Cortese; Josefin Nilsson; Carol Westall
Journal:  Doc Ophthalmol       Date:  2012-05-20       Impact factor: 2.379

5.  Focal macular photopic negative response in patients with optic neuritis.

Authors:  H Nakamura; K Miyamoto; S Yokota; K Ogino; N Yoshimura
Journal:  Eye (Lond)       Date:  2011-01-07       Impact factor: 3.775

6.  Oscillatory potentials of multifocal electroretinogram retinopathy.

Authors:  Hiroyuki Onozu; Shuichi Yamamoto
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

7.  A new mutation in the RP1L1 gene in a patient with occult macular dystrophy associated with a depolarizing pattern of focal macular electroretinograms.

Authors:  Takenori Kabuto; Hisatomo Takahashi; Yoko Goto-Fukuura; Tsutomu Igarashi; Masakazu Akahori; Shuhei Kameya; Takeshi Iwata; Atsushi Mizota; Kunihiko Yamaki; Yozo Miyake; Hiroshi Takahashi
Journal:  Mol Vis       Date:  2012-04-24       Impact factor: 2.367

8.  Cone dystrophy in patient with homozygous RP1L1 mutation.

Authors:  Sachiko Kikuchi; Shuhei Kameya; Kiyoko Gocho; Said El Shamieh; Keiichiro Akeo; Yuko Sugawara; Kunihiko Yamaki; Christina Zeitz; Isabelle Audo; Hiroshi Takahashi
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

Review 9.  Neuroinflammatory responses in diabetic retinopathy.

Authors:  Ying Yu; Hui Chen; Shao Bo Su
Journal:  J Neuroinflammation       Date:  2015-08-07       Impact factor: 8.322

10.  Assessment of Macular Function during Vitrectomy: New Approach Using Intraoperative Focal Macular Electroretinograms.

Authors:  Celso Soiti Matsumoto; Kei Shinoda; Gaku Terauchi; Harue Matsumoto; Atsushi Mizota; Yozo Miyake
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.